The worldwide incidence of primary brain tumors in 2015 was estimated to be 10.82 per 100,000 people per year.

Histologically confirmed meningiomas accounted for 37.6% of all primary central nervous system tumors and 50% of all benign primary central nervous system tumors. It affects approximately 1.8 to 13 per 100,000 individuals per year.

Meningioma is more common in adults than in children, with an incidence of 37.75 per 100,000 in the 75 to 84 age group. Whereas 0.14 per 100,000 in children from 0 to 19 years of age. Neurofibromatosis type 2 is associated with approximately 1% of meningiomas.

According to the WHO grades for meningioma, 80-81% are considered typical or grade 1. While 17 to 18% of them are atypical or grade 2, and 1.7% are anaplastic or grade 3 meningiomas.

Spinal meningiomas account for 30.7 to 38.8% of all primary intradural spinal tumors in the United States in those patients aged 20 years and older, with an age-adjusted incidence of 0.193 per 100,000 of the population.